Geode Capital Management’s Inhibikase Therapeutics IKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Buy |
1,066,700
+741,940
| +228% | +$1.45M | ﹤0.01% | 3125 |
|
|
2025
Q1 | $711K | Buy |
324,760
+1,882
| +0.6% | +$4.12K | ﹤0.01% | 3419 |
|
|
2024
Q4 | $1.05M | Buy |
322,878
+272,813
| +545% | +$887K | ﹤0.01% | 3362 |
|
|
2024
Q3 | $65.1K | Buy |
50,065
+12,735
| +34% | +$16.6K | ﹤0.01% | 4207 |
|
|
2024
Q2 | $48.9K | Buy |
37,330
+8,638
| +30% | +$11.3K | ﹤0.01% | 4287 |
|
|
2024
Q1 | $62K | Hold |
28,692
| – | – | ﹤0.01% | 4274 |
|
|
2023
Q4 | $36.5K | Hold |
28,692
| – | – | ﹤0.01% | 4422 |
|
|
2023
Q3 | $40.5K | Buy |
28,692
+13,852
| +93% | +$19.5K | ﹤0.01% | 4467 |
|
|
2023
Q2 | $51.6K | Sell |
14,840
-74,208
| -83% | -$258K | ﹤0.01% | 4500 |
|
|
2023
Q1 | $58.6K | Hold |
89,048
| – | – | ﹤0.01% | 4483 |
|
|
2022
Q4 | $44K | Sell |
89,048
-178
| -0.2% | -$88 | ﹤0.01% | 4627 |
|
|
2022
Q3 | $81K | Hold |
89,226
| – | – | ﹤0.01% | 4642 |
|
|
2022
Q2 | $66K | Buy |
89,226
+5,017
| +6% | +$3.71K | ﹤0.01% | 4707 |
|
|
2022
Q1 | $124K | Buy |
84,209
+5,081
| +6% | +$7.48K | ﹤0.01% | 4575 |
|
|
2021
Q4 | $116K | Buy |
79,128
+53,295
| +206% | +$78.1K | ﹤0.01% | 4677 |
|
|
2021
Q3 | $49K | Buy |
+25,833
| New | +$49K | ﹤0.01% | 4784 |
|